Increased hippocampal atrophy rates in AD over 6 months using serial MR imaging

Neurobiology of Aging

Volumn 29, Issue 8, 2008, Pages 1199-1203

  Barnes, J ^a   Scahill, R I ^a   Frost, C ^a,b   Schott, J M ^a   Rossor, M N ^a,c   Fox, N C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Atrophy rate; Hippocampus; MRI; Scanning interval

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AGED; AGING; ALZHEIMER DISEASE; ATROPHY; BRAIN; FEMALE; HIPPOCAMPUS; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; SUBTRACTION TECHNIQUE;

EID: 44949101390     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.02.011     Document Type: Article

References (14)

1. Bradley K.M., Bydder G.M., Budge M.M., Hajnal J.V., White S.J., Ripley B.D., and Smith A.D. Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease. Br. J. Radiol. 75 (2002) 506-513
2. Dawbarn D., and Allen S.J. Neurobiology of Alzheimer's Disease. second ed. (2001), Oxford University Press
3. Duvernoy H.M. The Human Hippocampus. second ed. (1998), Springer-Verlag
4. Fox N.C., Scahill R.I., Crum W.R., and Rossor M.N. Correlation between rates of brain atrophy and cognitive decline in AD. Neurology 52 (1999) 1687-1689
5. Freeborough P.A., Fox N.C., and Kitney R.I. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput. Methods Programs Biomed. 53 (1997) 15-25
6. Jack C.R., Slomkowski M., Gracon S., Hoover T.M., Felmlee J.P., Stewart K., Xu Y., Shiung M., O'Brien P.C., Cha R., Knopman D., and Petersen R.C. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 60 (2003) 253-260
7. Kantarci K., and Jack Jr. C.R. Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease. NeuroRx 1 (2004) 196-205
8. Krishnan K.R., Charles H.C., Doraiswamy P.M., Mintzer J., Weisler R., Yu X., Perdomo C., Ieni J.R., and Rogers S. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am. J. Psychiatry 160 (2003) 2003-2011
9. Mazziotta J.C., Toga A.W., Evans A., Fox P., and Lancaster J. A probabilistic atlas of the human brain: theory and rationale for its development. Neuroimage 2 (1995) 89-101
10. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's Disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
11. Scahill R.I., Frost C., Jenkins R., Whitwell J.L., Rossor M.N., and Fox N.C. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch. Neurol. 60 (2003) 989-994
12. Schott J.M., Price S.L., Frost C., Whitwell J.L., Rossor M.N., and Fox N.C. Measuring atrophy in Alzheimer disease-a serial MRI study over 6 and 12 months. Neurology 65 (2005) 119-124
13. Watson C., Andermann F., Gloor P., Jones-Gotman M., Peters T., Evans A., Olivier A., Melanson D., and Leroux G. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 42 (1992) 1743-1750
14. Whitwell J.L., Schott J.M., Lewis E.B., MacManus D.G., and Fox N.C. Using nine degrees-of-freedom registration to correct for changes in voxel size in serial MRI studies. Magn. Reson. Imaging 22 (2004) 993-999